Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data
By: Sang Gune K. Yoo, Grace S. Chung, Silver K. Bahendeka, Abla M. Sibai, Albertino Damasceno, Farshad Farzadfar, Peter Rohloff, Corine Houehanou, Bolormaa Norov, Khem B. Karki, Mohammadreza Azangou-Khyavy, Maja E. Marcus, Krishna K Aryal, Luisa C. C. Brant, Michaela Theilmann, Renata Cífková, Nuno Lunet, Mongal S. Gurung, Joseph Kibachio Mwangi, Joao Martins, Rosa Haghshenas, Lela Sturua, Sebastian Vollmer, Till Bärnighausen, Rifat Atun, Jeremy B. Sussman, Kavita Singh, Sahar Saeedi Moghaddam, David Guwatudde, Pascal Geldsetzer, Jennifer Manne-Goehler, Mark D. Huffman, Justine I. Davies and David Flood
References
- Arnett, DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. Circulation. 2019; 140: e596–646. DOI: 10.1161/CIR.0000000000000678
- Yoo SGK, Chung GS, Bahendeka SK, Sibai AM, Damasceno A, Farzadfar F, et al. Aspirin for secondary prevention of cardiovascular disease in 51 low-, middle-, and high-income countries. JAMA. 2023; 330: 715–24. DOI: 10.1001/jama.2023.12905
- The WHO CVD Risk Chart Working Group, Kaptoge S, Pennells L, Bacquer DD, Cooney MT, Kavousi M, et al. World Health Organization cardiovascular disease risk charts: Revised models to estimate risk in 21 global regions. Lancet Global Health. 2019; 7: e1332–45. DOI: 10.1016/S2214-109X(19)30318-3
- The World Bank. World Bank Country and Lending Groups n.d.
https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups (accessed January 18, 2023). - Lloyd-Jones DM, Huffman MD, Karmali KN, Sanghavi DM, Wright JS, Pelser C, et al. Estimating longitudinal risks and benefits from cardiovascular preventive therapies among medicare patients. Circulation. 2017; 135: e793–813. DOI: 10.1161/CIR.0000000000000467
- Dehmer SP, O’Keefe LR, Evans CV, Guirguis-Blake JM, Perdue LA, Maciosek MV. Aspirin use to prevent cardiovascular disease and colorectal cancer. JAMA. 2022; 327: 1598–607. DOI: 10.1001/jama.2022.3385
- Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: Understanding time lags in translational research. Journal of the Royal Society of Medicine. 2011; 104: 510–20. DOI: 10.1258/jrsm.2011.110180
DOI: https://doi.org/10.5334/gh.1323 | Journal eISSN: 2211-8179
Language: English
Submitted on: Apr 30, 2024
Accepted on: Apr 16, 2024
Published on: May 3, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2024 Sang Gune K. Yoo, Grace S. Chung, Silver K. Bahendeka, Abla M. Sibai, Albertino Damasceno, Farshad Farzadfar, Peter Rohloff, Corine Houehanou, Bolormaa Norov, Khem B. Karki, Mohammadreza Azangou-Khyavy, Maja E. Marcus, Krishna K Aryal, Luisa C. C. Brant, Michaela Theilmann, Renata Cífková, Nuno Lunet, Mongal S. Gurung, Joseph Kibachio Mwangi, Joao Martins, Rosa Haghshenas, Lela Sturua, Sebastian Vollmer, Till Bärnighausen, Rifat Atun, Jeremy B. Sussman, Kavita Singh, Sahar Saeedi Moghaddam, David Guwatudde, Pascal Geldsetzer, Jennifer Manne-Goehler, Mark D. Huffman, Justine I. Davies, David Flood, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.